Serum Peptidome Profiles Immune Response of COVID-19 Vaccine Administration

ABSTRACT: The study shows the promise of MALDI-TOF MS-based serum peptidome analysis for the assessment of immune responses activated by COVID-19 vaccination, and discovered a panel of serum peptides biomarkers for COVID-19 vaccination and for NAbs generation. The method developed in this study can help not only in the development of new vaccines, but also in the postmarketing evaluation of developed vaccines.

ORGANISM(S): Homo Sapiens

SUBMITTER: Liang Qiao  

PROVIDER: PXD036159 | iProX | Fri Aug 19 00:00:00 BST 2022

REPOSITORIES: iProX